Neonatal Hepatic Drug Elimination
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
After the transition from in utero to newborn life, the neonate becomes solely reliant upon its own drug clearance processes to metabolise xenobiotics. Whilst most studies of neonatal hepatic drug elimination have focussed upon in vitro expression and activities of drug‐metabolising enzymes, the rapid physiological changes in the early neonatal period of life also need to be considered. There are dramatic changes in neonatal liver blood flow and hepatic oxygenation due to the loss of the umbilical blood supply, the increasing portal vein blood flow, and the gradual closure of the ductus venosus shunt during the first week of life. These changes which may well affect the capacity of neonatal hepatic drug metabolism. The hepatic expression of cytochromes P450 1A2, 2C, 2D6, 2E1 and 3A4 develop at different rates in the postnatal period, whilst 3A7 expression diminishes. Hepatic glucuronidation in the human neonate is relatively immature at birth, which contrasts with the considerably more mature neonatal hepatic sulfation activity. Limited in vivo studies show that the human neonate can significantly metabolise xenobiotics but clearance is considerably less compared with the older infant and adult. The neonatal population included in pharmacological studies is highly heterogeneous with respect to age, body weight, ductus venosus closure and disease processes, making it difficult to interpret data arising from human neonatal studies. Studies in the perfused foetal and neonatal sheep liver have demonstrated how the oxidative and conjugative hepatic elimination of drugs by the intact organ is significantly increased during the first week of life, highlighting that future studies will need to consider the profound physiological changes that may influence neonatal hepatic drug elimination shortly after birth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Christopher Gorski, J., Hall, S. D., Jones, D. R., & VandenBranden, M. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90543-6 · Cited by 395
Diazepam elimination in premature and full term infants, and children
Morselli, P. L., Principi, N., Tognoni, G., Reali, E., Belvedere, G., Standen, S. M., & Sereni, F. (1973) · Journal of Perinatal Medicine · doi:10.1515/jpme.1973.1.2.133 · Cited by 116
Nicotine metabolism and elimination kinetics in newborns
Dempsey, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106129 · Cited by 112
Cited by
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,818
EFSA Panel on Food Contact Materials, E. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.3978 · Cited by 1,023
Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A
Hengstler, J. G., Foth, H., Gebel, T., Kramer, P.-J., Lilienblum, W., Schweinfurth, H., Völkel, W., Wollin, K.-M., & Gundert-Remy, U. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.558487 · Cited by 346
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants: Part I
Alcorn, J., & McNamara, P. J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00003 · Cited by 333
Metadata
- Authors
- Gow, P. J., Ghabrial, H., Smallwood, R. A., Morgan, D. J., & Ching, M. S.
- Venue
- Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 88
- Issue
- 1
- Pages
- 3-15
- ISSN
- 0901-9928 (ISSN-L)
- OpenAlex
- W2162674333
- Cited by
- 122
- References
- 4
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neonatal Hepatic Drug Elimination. https://app.cochat.ai/papers/10.1034/j.1600-0773.2001.088001003.x
- The paper
- Gow, P. J., Ghabrial, H., Smallwood, R. A., Morgan, D. J., & Ching, M. S. (2001). Neonatal Hepatic Drug Elimination. Pharmacology & Toxicology. https://doi.org/10.1034/j.1600-0773.2001.088001003.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.